Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.00 is 59% below its 5-year average of 2.43, near the low end of its 5-year range (0.86–7.11).
As of the fiscal period ended Tuesday, June 30, 2026. 2.86% below its 12-month average of 1.03.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.00.
QUICK RATIO (ACID-TEST)
1.00
QUICK RATIO (ACID-TEST) AVG TTM
1.03
QUICK RATIO (ACID-TEST) AVG 3Y
1.38
QUICK RATIO (ACID-TEST) AVG 5Y
2.43
QUICK RATIO (ACID-TEST) AVG 10Y
3.29
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-2.86%
CURRENT VS 3Y AVG
-27.20%
CURRENT VS 5Y AVG
-58.76%
CURRENT VS 10Y AVG
-69.50%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.07
median of 689 covered companies
CURRENT VS SECTOR MEDIAN
-67.34%
vs the sector median at left
electroCore, Inc.
Market Cap
$91.51M
Quick Ratio (Acid-Test)
1.00
TTM Avg
1.03
3Y Avg
1.38
5Y Avg
2.43
Market Cap
$92.31M
Quick Ratio (Acid-Test)
23.40
TTM Avg
7.13
3Y Avg
4.61
5Y Avg
6.59
Market Cap
$93.47M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$93.27M
Quick Ratio (Acid-Test)
3.47
TTM Avg
4.19
3Y Avg
5.60
5Y Avg
16.48
Market Cap
$94.01M
Quick Ratio (Acid-Test)
4.50
TTM Avg
8.19
3Y Avg
12.95
5Y Avg
15.06
Market Cap
$89.33M
Quick Ratio (Acid-Test)
7.70
TTM Avg
11.16
3Y Avg
14.97
5Y Avg
23.58
Market Cap
$89.11M
Quick Ratio (Acid-Test)
2.71
TTM Avg
1.86
3Y Avg
1.80
5Y Avg
2.82
Market Cap
$96.58M
Quick Ratio (Acid-Test)
1.12
TTM Avg
0.72
3Y Avg
0.57
5Y Avg
0.57
Market Cap
$86.90M
Quick Ratio (Acid-Test)
1.01
TTM Avg
1.14
3Y Avg
1.20
5Y Avg
1.25
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| electroCore, Inc. (ECOR) | $91.51M | 1.00 | 1.03 | 1.38 | 2.43 |
| Equillium, Inc. (EQ)vs › | $92.31M | 23.40 | 7.13 | 4.61 | 6.59 |
| Conexeu Sciences Inc. (CNXU)vs › | $93.47M | N/A | N/A | N/A | N/A |
| Biomea Fusion, Inc. (BMEA)vs › | $93.27M | 3.47 | 4.19 | 5.60 | 16.48 |
| Neumora Therapeutics, Inc. Common Stock (NMRA)vs › | $94.01M | 4.50 | 8.19 | 12.95 | 15.06 |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.33M | 7.70 | 11.16 | 14.97 | 23.58 |
| ImmuCell Corporation (ICCC)vs › | $89.11M | 2.71 | 1.86 | 1.80 | 2.82 |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $96.58M | 1.12 | 0.72 | 0.57 | 0.57 |
| CareCloud, Inc. (CCLD)vs › | $86.90M | 1.01 | 1.14 | 1.20 | 1.25 |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $85.01M | 1.98 | 0.61 | 1.40 | 2.59 |
Quick Ratio
1.00
Excludes inventory
Current Ratio
1.21
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.00 |
| 2026-03-31 | 0.86 |
| 2025-12-31 | 1.02 |
| 2025-09-30 | 1.33 |
| 2025-06-30 | 0.95 |
| 2025-03-31 | 1.30 |
| 2024-12-31 | 1.60 |
| 2024-09-30 | 1.87 |
| 2024-06-30 | 2.12 |
| 2024-03-31 | 1.18 |
| 2023-12-31 | 1.49 |
| 2023-09-30 | 1.80 |
| 2023-06-30 | 1.37 |
| 2023-03-31 | 2.21 |
| 2022-12-31 | 2.72 |
| 2022-09-30 | 3.51 |
| 2022-06-30 | 4.85 |
| 2022-03-31 | 6.60 |
| 2021-12-31 | 6.60 |
| 2021-09-30 | 7.11 |
| 2021-06-30 | 4.23 |
| 2021-03-31 | 4.99 |
| 2020-12-31 | 4.11 |
| 2020-09-30 | 4.78 |
| 2020-06-30 | 3.77 |
| 2020-03-31 | 2.28 |
| 2019-12-31 | 2.80 |
| 2019-09-30 | 3.50 |
| 2019-06-30 | 5.93 |
| 2019-03-31 | 10.07 |
| 2018-12-31 | 10.00 |
| 2018-09-30 | 17.59 |
| 2018-06-30 | 14.32 |
| 2018-03-31 | 4.06 |
| 2017-12-31 | 6.33 |
| 2017-09-30 | 0.00 |
| 2017-06-30 | 0.00 |
| 2017-03-31 | 0.00 |
